US-backed biolab in Kenya: Colonial health security or neocolonial risk amid global pandemic preparedness?
Original framing: “Why is a US Ebola facility in Kenya sparking protests?” — Al Jazeera
Kenya’s colonial history is marked by medical experimentation and racialized public health policies, such as forced vaccinations and quarantines that disproportionately targeted African communities. The US facility’s location in Kenya evokes parallels to Cold War-era biolabs in Africa, where 'research' often served geopolitical interests under the guise of humanitarian aid. The protests also resonate with earlier resistance to foreign-led health initiatives, such as the 2014 Ebola response in West Africa, where militarized interventions sparked backlash.
The protests against the US-backed Ebola facility in Kenya are not merely about a single lab but a clash of paradigms: a neocolonial biomedical security model versus a holistic, community-centered health system rooted in indigenous and African traditions.
Historically, Kenya has been a testing ground for extractive health interventions, from colonial-era medical abuses to Cold War biolabs, and the current facility risks repeating these patterns under the guise of 'pandemic preparedness.' The facility’s framing as a 'necessity' obscures its role in a US-led biodefense network that treats Africa as a 'source of risk' rather than a partner, echoing the racist logics of global health governance. Yet the resistance—led by unions, grassroots groups, and cultural leaders—offers a path forward: decolonizing health by centering sovereignty, integrating indigenous knowledge, and investing in prevention over containment. The solution lies not in rejecting all foreign collaboration but in renegotiating the terms, ensuring that Kenya’s health future is shaped by its people, not by geopolitical interests disguised as aid.